Does Wegovy Increase Gallstone Risk?
Yes, Wegovy (semaglutide) can increase the risk of gallstones and related gallbladder problems. Clinical trials showed higher rates of cholelithiasis (gallstones) in patients taking Wegovy compared to placebo. In the STEP 1 trial, 2.6% of Wegovy users developed gallstones versus 1.2% on placebo.[1] This risk stems from rapid weight loss, which Wegovy induces by mimicking GLP-1 hormone to slow gastric emptying and reduce appetite—both factors that promote gallstone formation by concentrating bile.[2]
How Common Are Gallbladder Issues on Wegovy?
Gallbladder disorders occurred in about 4% of Wegovy patients across trials, including cholecystitis (gallbladder inflammation) and cholelithiasis. Events were more frequent at higher doses (2.4 mg weekly) and with faster weight loss. Post-approval data from Novo Nordisk reports similar patterns, with some cases requiring surgery like cholecystectomy.[1][3]
What Symptoms Should Wegovy Users Watch For?
Signs of gallstones or gallbladder issues include upper abdominal pain (especially after fatty meals), nausea, vomiting, fever, or jaundice. These can appear weeks to months into treatment. The Wegovy label advises immediate medical attention for persistent symptoms.[1]
Why Does Weight Loss Medication Like Wegovy Cause This?
GLP-1 agonists like Wegovy trigger significant fat loss (up to 15-20% body weight in trials), which reduces gallbladder motility and alters bile composition, leading to stone formation. This isn't unique to Wegovy—similar risks occur with other semaglutide products (Ozempic, Rybelsus) and older weight loss drugs.[2][4]
Can You Prevent Gallstones While on Wegovy?
No proven prevention exists, but strategies include gradual weight loss (under doctor supervision), staying hydrated, and a balanced diet low in fats. Some doctors recommend baseline ultrasound screening for at-risk patients (e.g., those with obesity or prior gallstones). Discontinuing Wegovy may resolve issues, but stones can persist.[3]
What If You Already Have Gallstones?
Patients with existing gallstones face higher complication risks on Wegovy. The label contraindicates use in acute gallbladder disease and urges caution otherwise. Consult a doctor—surgery might be needed before or during treatment.[1]
Sources
[1]: Wegovy Prescribing Information (FDA)
[2]: NEJM STEP Trials on Semaglutide
[3]: Novo Nordisk Wegovy Safety Data
[4]: Mayo Clinic on GLP-1 Drugs and Gallstones